Business Wire

Evaluate Ltd. transforms pharma R&D risk assessment with launch of Product Specific PTRS

Share

Evaluate Ltd., the leading provider of commercial intelligence to the pharmaceutical industry, today released its latest data breakthrough, Product Specific PTRS, as part of its commitment to transforming the way biopharma companies and their advisors manage the risks of novel drug development.

Product Specific PTRS (probability of technical and regulatory success) is the first fully transparent, product-level assessment of the likelihood a drug will reach the market. Covering all NMEs and NDAs currently in clinical development, Product Specific PTRS combines a machine learning platform with an analysis of over 50 drug, company and market attributes and 30,000+ historic phase transitions. As a result, Product Specific PTRS predicts a drug’s probability of success based on its individual characteristics, substantially improving on the accuracy of general industry or indication success rate benchmarks.

“Machine-learning models offer unprecedented accuracy, given the high number of attributes they can factor into their calculations,” said Jon Moser, Head of Product Development. “However, they lack the transparency needed by biopharma executives to evaluate the drivers of risk. Our unique model combines the accuracy of machine learning with a detailed breakdown of the product-level attributes that improve or degrade a product’s risk profile.”

“With only 51% of novel phase three clinical products obtaining FDA approval, and the significant costs of a phase three program, drugmakers are under more pressure than ever to make sound, evidence-based decisions on how to invest in their pipelines,” said CEO Deborah Kobewka. “As part of our EvaluatePharma Vision platform, Product-Specific PTRS is the latest effort to support companies managing clinical portfolios in light of rising development costs and increased pricing concerns.”

Key Product Features:

  • Unique risk calculations at the product level allow for differentiation between similar products or streamlined risk analysis across a portfolio.
  • Detailed risk audits show the individual factors that have the greatest influence on a product’s probability of success, as well as the relative impact of each factor.
  • Probability of success available for products with novel mechanism of actions or indications without previous approvals, removing limitations created by traditional success rate benchmarks.
  • Fully integrated with EvaluatePharma Vision commercial and development data, including net present value, product-level R&D costs, clinical timelines, consensus sales forecasts and more.

Learn more about Product Specific PTRS, EvaluatePharma Vision, and how Evaluate increases confidence in strategic decisions at www.evaluate.com.

About Evaluate Ltd.

Evaluate provides trusted commercial intelligence for the pharmaceutical and medical device industries. Our EvaluatePharma® and EvaluatePharma Vision online subscription services provide a seamless view of the past, present and future of the global pharmaceutical market in a single, standardised platform.

Vantage – our award-winning, independent editorial team – provides thought-provoking news and insights into the current and future developments in the industry.

Evaluate has been a partner to industry-leading organisations for over 20 years. For more information on how we give our clients the time and understanding to drive better decisions, visit www.evaluate.com .

Follow us on Twitter: @EvaluatePharma, @Vantageanalysis

Contact information

Media Contact:
Evaluate and Vantage
Jennifer Dinkel
+1 617-936-7783
jennifer.dinkel@evaluate.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

nCipher Introduces Cloud-first Architecture, Bringing Security and Control to Public and Private Clouds29.1.2020 11:00:00 EETPress release

nCipher Security, an Entrust Datacard company and provider of trust, integrity and control for business critical information and applications, announces two new additions to its nShield® hardware security module (HSM) portfolio – nShield Web Services Option Pack and nShield Container Option Pack – that make it simpler to deploy applications in the cloud and bring greater security and control to public and private clouds. nShield Web Services Option Pack simplifies deployment for cloud-first data centres. nShield Web Services Option Pack provides a REST API between applications requiring cryptographic key and data protection services and nShield HSMs, enabling seamless application deployment underpinned by high-assurance nShield HSMs, which can dynamically scale to meet the needs of cloud-ready data centers. Customers can also use their own load balancing appliances to handle the HSM workload, simplifying the HSM deployment and configuration, and ensuring the best utilization of their H

Denenchofufutaba Gakuen, NTT Group Start a Joint Study to Create Smart Campus Solutions29.1.2020 10:32:00 EETPress release

NTT Group (Nippon Telegraph and Telephone Corporation (Hereinafter, NTT), NTT DATA Corporation, NTT COMWARE Corporation, NTT Communications Corporation, NTT Ltd., Nippon Telegraph and Telephone East Corporation (Hereinafter, NTT East)) will begin a joint study with Denenchofufutaba Gakuen in order to develop smart campus solutions that will provide safety and security at schools. NTT Group implements technology of public safety solution that will draw on the proven implementation for the City of Las Vegas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200128005916/en/ Solution Overview (Graphic: Business Wire) 1. Background In recent years, there have been several crimes and incidents involving students in school facilities, and resulting in requests to improve safety measures in addition to crime prevention activities by national and local governments. Furthermore, with the introduction of new educational guidelines, the w

Panasonic Develops High-Power Blue WBC Technology to Revolutionize DDL Applications on Microfabrication29.1.2020 09:11:00 EETPress release

On January 29, 2020, Panasonic Corporation announced it has succeeded in demonstrating the world's highest brightness blue laser. This has been achieved by using the wavelength beam combining (WBC) technology [1] on a direct diode laser (DDL) to produce a high quality output beam [2]. With this technology, power scaling is enabled while maintaining the beam quality by simply increasing the number of laser sources. This demonstration opens the door to laser intensities that could be two orders of magnitude higher than conventional blue laser systems. This technology will contribute to the emerging microfabrication processes, whose demand is expected to grow in industrial applications, such as in the automotive industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200128005907/en/ Wavelength Beam Combining (WBC) technology (Graphic: Business Wire) The automotive industry is moving towards “electrification” and “miniaturizat

NTT Group to Launch Asia's First Smart City Proof of Concept Collaborating with Cyberview and Allo in Malaysia29.1.2020 09:00:00 EETPress release

As part of the Japanese Ministry of Internal Affairs and Communications’ FY 2019 project "Research on Smart City Model for Solving Social Problems in Malaysia", based on the smart city initiatives which has been started with the City of Las Vegas, United States, NTT Group (Nippon Telegraph and Telephone Corporation (Hereinafter, NTT), NTT Communications Corporation, NTT Ltd., InfoCom Research, Inc., NTT DATA Corporation, NTT COMWARE Corporation) will conduct Asia's one of the first Smart City Proof of Concept (PoC) in the Cyberjaya area of Malaysia from February 2020, in cooperation with local stakeholders. Through this PoC, NTT Group aims to establish a sustainable business model while verifying the possibility of solving social issues in Asia, utilizing the technologies and know-how accumulated in the smart city field in the United States. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200128005904/en/ (Graphic: Business W

Kioxia Appoints Masaki Momodomi as Chief Technology Officer29.1.2020 07:00:00 EETPress release

Kioxia Holdings Corporation today announced the appointment of Masaki Momodomi as Chief Technology Officer (CTO) of Kioxia, effective immediately. Mr. Momodomi fills the role of Former CTO Nobuo Hayasaka, who has been appointed as President and Chief Executive Officer (CEO) of Kioxia. Mr. Momodomi has an accomplished background in the memory industry, bringing over 40 years of experience across roles at Kioxia, Toshiba Memory and Toshiba Corporation. Following Toshiba Memory’s separation from Toshiba Corporation, Mr. Momodomi was named director of Toshiba Memory, now Kioxia’s Institute of Memory Technology Research and Development. Previously, he served as director of Toshiba Corporation’s Center of Semiconductor Research and Development. A pioneer in the memory field, in 1987, Mr. Momodomi co-authored a dissertation on Toshiba’s invention of NAND Flash memory, playing a vital role in the exponential growth of the now ubiquitous technology. Mr. Momodomi graduated from Kyushu University

Kioxia Appoints Nobuo Hayasaka as President and CEO29.1.2020 07:00:00 EETPress release

Kioxia Holdings Corporation today announced that the Board of Directors has appointed Nobuo Hayasaka as President and CEO of Kioxia, effective immediately. Dr. Hayasaka has served as Acting President and CEO since July 12, 2019, during Former President and CEO Yasuo Naruke’s medical leave of absence. Dr. Naruke notified the company’s Board of Directors of his desire to step down as President, CEO and member of the board as he continues to focus on his health. “Dr. Naruke has been an outstanding leader for our company over many years, and we thank him for the invaluable contribution he has made to shaping us into the company we are today.” said Stacy J. Smith, Executive Chairman of Kioxia. “This year presents an exciting opportunity for Kioxia, and President Hayasaka has the skills, experience and the full backing of our Board of Directors, management and employees as we move toward a new era of memory. I look forward to working closely with President Hayasaka and the rest of the execut

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom